Drugs / Coolprep
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT01919255 Comparator | Aug 2013 → Sep 2014 | — | National Cancer Center, Korea | Completed | No outcome recorded |
| Phase 3 | NCT05870553 Comparator | Jan → May 2023 | — | Taejoon Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 3 | NCT01745835 Comparator | Jan → Aug 2013 | — | Seoul National University Hospital | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cool prep | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05870553 ↗ |
| Known as | 2L Coolprep (TaeJoon Pharmaceuticals, Seoul, Korea) | “2L Coolprep® (TaeJoon Pharmaceuticals, Seoul, Korea)” NCT01745835 ↗ |